Spontaneous bacterial peritonitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the [[immune system]] to eradicate the organisms once they have escaped.<ref name="pmid4018735">{{cite journal| author=Runyon BA, Morrissey RL, Hoefs JC, Wyle FA| title=Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. | journal=Hepatology | year= 1985 | volume= 5 | issue= 4 | pages= 634-7 | pmid=4018735 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4018735  }} </ref><ref name="pmid15138202">{{cite journal| author=Runyon BA| title=Early events in spontaneous bacterial peritonitis. | journal=Gut | year= 2004 | volume= 53 | issue= 6 | pages= 782-4 | pmid=15138202 | doi= | pmc=1774068 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15138202  }} </ref><ref name="pmid15920324">{{cite journal| author=Sheer TA, Runyon BA| title=Spontaneous bacterial peritonitis. | journal=Dig Dis | year= 2005 | volume= 23 | issue= 1 | pages= 39-46 | pmid=15920324 | doi=10.1159/000084724 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15920324  }} </ref>
SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the [[immune system]] to eradicate the organisms once they have escaped.<ref name="pmid4018735">{{cite journal| author=Runyon BA, Morrissey RL, Hoefs JC, Wyle FA| title=Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. | journal=Hepatology | year= 1985 | volume= 5 | issue= 4 | pages= 634-7 | pmid=4018735 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4018735  }} </ref><ref name="pmid15138202">{{cite journal| author=Runyon BA| title=Early events in spontaneous bacterial peritonitis. | journal=Gut | year= 2004 | volume= 53 | issue= 6 | pages= 782-4 | pmid=15138202 | doi= | pmc=1774068 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15138202  }} </ref><ref name="pmid15920324">{{cite journal| author=Sheer TA, Runyon BA| title=Spontaneous bacterial peritonitis. | journal=Dig Dis | year= 2005 | volume= 23 | issue= 1 | pages= 39-46 | pmid=15920324 | doi=10.1159/000084724 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15920324  }} </ref>.'''[[Spontaneous bacterial peritonitis]] is thought to result from a combination of factors related to [[cirrhosis]] and [[ascites]] such as''': Altered microbial flora, Hypo-motility of the intestine, Intestinal bacterial overgrowth, Increased Intestinal mucosal [[permeability]], Bacterial translocation to [[Lymph nodes]]. Presence of [[ascites]] appears to be an important risk factor for the development of bacterial [[translocation]]. In healthy individuals, bacteria that colonize [[lymph nodes]] are killed by local immune defenses. '''However, in the setting of [[cirrhosis]], an [[acquired]] state of [[Immunodeficiency]] there is''': Malfunctioning of the [[Reticulo-endothelial system|reticulo-endothelial]] and neutrophilic system, Reduced [[Cellular]] and [[Humoral]] [[bactericidal]] function which favor the spread of [[bacteria]] to the [[blood stream]]. '''Alterations in the [[systemic]] [[immune response]]''': [[Bacteremia]] in a healthy host results in rapid coating by [[IgG]]  and/or [[Complement]] components and then engulfing and killing by circulating [[neutrophils]]. '''But in [[cirrhosis]], as stated above several abnormalities have been described including''' : Decreased serum levels of [[complement]] components (C3, C4), Impaired [[chemotaxis]], Poor function and [[phagocytic]] activity of [[neutrophils]], Decreased function of [[Fc receptor|Fc]]-gamma-receptors in [[macrophages]]. '''[[Reticuloendothelial system]] [[phagocytic]] activity''': The stationary [[macrophages]], such as the [[Kupffer cell|Kupffer cells]] of the liver, assist the circulating [[neutrophils]] in the extraction and killing of particulate matter (e.g., bacteria) from the systemic circulation. In Cirrhosis, there is Hepatic [[Reticuloendothelial system]] (RES) dysfunction, [[Kupffer cells]] are decreased in number with impaired function along with the malfunctioning of the neutrophilic system. Patients with the most severe dysfunction of RES have the highest risk of [[bacteremia]] and concomitant shortened survival, due to [[sepsis]]. The presence of intrahepatic and extra hepatic porto-systemic shunts as a consequence of [[portal hypertension]], prevent circulating bacteria from encountering [[Kupffer cells]]. The final consequence of these abnormalities is the prolongation of [[bacteremia]] and eventual seeding of other sites, including AF. '''AF defense mechanisms:''' Decreased local AF opsonic activity: The arrival of bacteria to the AF does not guarantee that infection will develop. Cirrhotic AF is capable of [[humoral]] self-defense, mainly on the basis of effectiveness of the [[complement]] system, Patients with adequate activity of this vital [[bactericidal]] system usually do not develop AF bacterial infections, Patients with AF C3 < 1g/dl and a protein level < 1g/dl have an increased predisposition to [[SBP]], the [[complement]] levels may be deficient because of increased consumption of these components or because of impaired synthesis, if the [[complement]] levels are adequate to effectively kill the bacteria, infection will not develop, if [[complement]] levels are consumed and depleted, killing may be ineffective, frequent colonization of AF by bacteria decreases its antimicrobial ability and can eventually lead to the development of infection [[Bacteremia]]/ Endotoxemia leads to activation of [[cytokine]] cascade and some of these effector molecules and [[cytokines]] that help kill the bacteria have undesired side effects. [[NO]] and [[TNF]] are important mediators of the further [[vasodilation]] and [[renal failure]] that too often accompany [[SBP]]. [[Iatrogenic]] and treatment related factors like [[PPI]], and increased use of invasive procedures and catheters in patients with [[Cirrhosis]] and [[ascites]]. Other compelling factors like [[malnutrition]] and [[alcohol]] drinking also predispose to SBP.


==Pathophysiology==
==Pathophysiology==

Revision as of 14:53, 3 February 2017

Peritonitis main page

Spontaneous bacterial peritonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spontaneous bacterial peritonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Spontaneous bacterial peritonitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Spontaneous bacterial peritonitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Spontaneous bacterial peritonitis pathophysiology

CDC on Spontaneous bacterial peritonitis pathophysiology

Spontaneous bacterial peritonitis pathophysiology in the news

Blogs on Spontaneous bacterial peritonitis pathophysiology

Directions to Hospitals Treating Spontaneous bacterial peritonitis

Risk calculators and risk factors for Spontaneous bacterial peritonitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2] Shivani Chaparala M.B.B.S [3]

Overview

SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the immune system to eradicate the organisms once they have escaped.[1][2][3].Spontaneous bacterial peritonitis is thought to result from a combination of factors related to cirrhosis and ascites such as: Altered microbial flora, Hypo-motility of the intestine, Intestinal bacterial overgrowth, Increased Intestinal mucosal permeability, Bacterial translocation to Lymph nodes. Presence of ascites appears to be an important risk factor for the development of bacterial translocation. In healthy individuals, bacteria that colonize lymph nodes are killed by local immune defenses. However, in the setting of cirrhosis, an acquired state of Immunodeficiency there is: Malfunctioning of the reticulo-endothelial and neutrophilic system, Reduced Cellular and Humoral bactericidal function which favor the spread of bacteria to the blood stream. Alterations in the systemic immune response: Bacteremia in a healthy host results in rapid coating by IgG and/or Complement components and then engulfing and killing by circulating neutrophils. But in cirrhosis, as stated above several abnormalities have been described including : Decreased serum levels of complement components (C3, C4), Impaired chemotaxis, Poor function and phagocytic activity of neutrophils, Decreased function of Fc-gamma-receptors in macrophages. Reticuloendothelial system phagocytic activity: The stationary macrophages, such as the Kupffer cells of the liver, assist the circulating neutrophils in the extraction and killing of particulate matter (e.g., bacteria) from the systemic circulation. In Cirrhosis, there is Hepatic Reticuloendothelial system (RES) dysfunction, Kupffer cells are decreased in number with impaired function along with the malfunctioning of the neutrophilic system. Patients with the most severe dysfunction of RES have the highest risk of bacteremia and concomitant shortened survival, due to sepsis. The presence of intrahepatic and extra hepatic porto-systemic shunts as a consequence of portal hypertension, prevent circulating bacteria from encountering Kupffer cells. The final consequence of these abnormalities is the prolongation of bacteremia and eventual seeding of other sites, including AF. AF defense mechanisms: Decreased local AF opsonic activity: The arrival of bacteria to the AF does not guarantee that infection will develop. Cirrhotic AF is capable of humoral self-defense, mainly on the basis of effectiveness of the complement system, Patients with adequate activity of this vital bactericidal system usually do not develop AF bacterial infections, Patients with AF C3 < 1g/dl and a protein level < 1g/dl have an increased predisposition to SBP, the complement levels may be deficient because of increased consumption of these components or because of impaired synthesis, if the complement levels are adequate to effectively kill the bacteria, infection will not develop, if complement levels are consumed and depleted, killing may be ineffective, frequent colonization of AF by bacteria decreases its antimicrobial ability and can eventually lead to the development of infection Bacteremia/ Endotoxemia leads to activation of cytokine cascade and some of these effector molecules and cytokines that help kill the bacteria have undesired side effects. NO and TNF are important mediators of the further vasodilation and renal failure that too often accompany SBP. Iatrogenic and treatment related factors like PPI, and increased use of invasive procedures and catheters in patients with Cirrhosis and ascites. Other compelling factors like malnutrition and alcohol drinking also predispose to SBP.

Pathophysiology

 
 
Patients with decompensated cirrhosis leading to portal Hypertension[4][5]
 
 
 
 
 
 
 
 
 
Intestinal hypo-motility and local pro-inflammatory phenomenon[6]
 
 
 
 
 
 
 
 
 
Bacterial overgrowth:
Increased intestinal permeability and decreased local and systemic immune system in cirrhosis and its relation to bacterial infections and prognosis. [6][7][8]
 
 
 
 
 
 
 
 
 
Routes of entry of pathogens into the ascitic fluid
Escape of enteric bacteria to systemic circulation through:[9]
❑ Bacterial translocation[5]
• Luminal bacteria within colonize mesenteric lymph nodes.[10]
• Organisms from the mesenteric lymph nodes → Systemic circulation through thoracic duct lymph → percolates through the liver and weep across Glisson's capsule → Ascitic fluid.
• Transient bacteremia → Prolonged bacteremia ( due to ↓ Reticulo endothelial system activity ) → Ascites Colonization ( due to ↓ ascitic fluid bactericidal activity ) → Spontaneous bacterial peritonitis )
❑ Portal Vein
• Porto-systemic shunt
• ↓RES function in the liver
❑ Lymphatic rupture
• Contaminated lymph carried by lymphatics
• Ruptured Lymphatics due to high flow and high pressure associated with portal hypertension ( BACTERASCITES )[11]
❑ Other source of organisms
• IV catheters, skin, urinary, and respiratory tract
 
 
 
 
 
 
 
 
 
Endotoxemia and Cytokine response
❑ Endotoxemia → release of pro-inflammatory cytokines produced by macrophages and other host cells in response to bacteria in the serum and peritoneal exudate
Tumor necrosis factor-α (TNF-α)
Interleukin (IL)-1,6
Interferon-γ (IFN-γ)
Soluble adhesion molecules
❑ Systemic and Abdominal manifestations of peritonitis mediated by cytokines[12][2]
• The effector molecules (Nitric oxide) and cytokines,Tumour necrosis factor (TNF) that help kill the bacteria have undesired side effects as they cause vasodilation and renal failure that accompany SBP.[13][12][14]
• Studies have shown that the presence of whole bacteria or DNA, in serum and ascitic fluid leads to stimulation of immune defences, effector molecules, and cytokines which in turn impact on hemodynamics, renal function and survival.[13]
 
 
 
 
 
 
 
 
 
Host response
❑ Local response

Outpouring of fluid into the peritoneal cavity at sites of irritation with:

• High protein content (>3 g/dL)
• Many cells, primarily polymorphonuclear leukocytes, that phagocytose and kill organisms
• Formation of Fibrinous exudate on the inflamed peritoneal surfaces → Adhesion formation between adjacent bowel, mesentery, and omentum
• Localization of the inflammatory process is aided further by inhibition of motility in the involved intestinal loops
• The extent and rate of intraperitoneal spread of contamination depend on the volume and nature of the exudate and on the effectiveness of the localizing processes
• If peritoneal defenses aided by the appropriate supportive measures control the inflammatory process, the disease may resolve spontaneously (Sterile ascites)[1][1][11] → Consumption of humoral bactericidal factors due to frequent colonization → Increased susceptibility to SBP[15]
• If the ascitic fluid bactericidal activity is poor-moderate → Culture negative neutrocytic ascites (CNNA) or SBP → delay / inappropriate treatment → death due to sepsis and multi organ failure.[16][17]
• Second possible outcome is a confined abscess
• A third possible outcome results when the peritoneal and systemic defense mechanisms are unable to localize the inflammation, which progresses to spreading diffuse peritonitis due to increased virulence of bacteria, greater extent and duration of contamination, and impaired host defenses.
❑ Systemic response

Gastrointestinal

Paralysis of the bowel due to local inflammation
• Progressive accumulation of fluid and electrolytes in the lumen of the adynamic bowel → distention of the bowel → inhibition of the capillary inflow and secretions
• GI bleeding because of excessive inflammation and tissue damage → ↑ vasodilatation and ↓organ perfusion

Cardiovascular

• Shift of fluid into the peritoneal cavity and bowel lumen → ↓ Effective circulating blood volume → ↑ Hematocrit and
• ↑Fluid and electrolyte loss by coexistent fever, vomiting, diarrhea → decreased venous return to the right side of the heart → decrease in cardiac outputhypotension → activation of the sympathetic nervous system and manifestations such as sweating, tachycardia, and cutaneous vasoconstriction (i.e., cold, moist skin and mottled, cyanotic extremities).
• If the blood volume replaced is sufficient enough as so to increase the cardiac output 2-3 times normal ( to satisfy the increased metabolic needs of the body in the presence of infection) a halt in the progression of the disease is seen.
• Failure to sustain increased cardiac output results in progressive lactic acidosis, oliguria, hypotension, and ultimately death if the infection cannot be controlled.

Respiratory

Intra-peritoneal inflammation → high and fixed diaphragm → pain on respiration → basilar atelectasis with intrapulmonary shunting of blood
• Decompensation of respiratory function due to delay in the intervention → hypoxemia + hypo-capnia (respiratory alkalosis) followed by hypercapnia (respiratory acidosis)
Pulmonary edema results because of increased pulmonary capillary leakage as a consequence of hypo-albuminemia or direct effects of bacterial toxins (adult respiratory distress syndrome) → progressive hypoxemia with decreasing pulmonary compliance which needs a ventilator assistance with increasingly higher concentrations of inspired oxygen and positive end-expiratory pressure.

Renal

• SBP → Splanchnic arterial vasodilation and systemic vascular resistance → ↓ Effective arterial blood volume → stimulation of systemic vasoconstrictors (RAAS, Sympathetic Nervous System, Arginine vasopressin) → renal vasoconstriction
• Advanced cirrhosis → ↓ production of local vasodilators and ↑ production of local vasoconstrictors[12] → Hepatorenal syndrome and death.[2]
• ↓ Organ perfusion → Ischemic and Toxic Acute Tubular NecrosisAcute Renal Failure → Death in (30-40%) of patients.

Metabolic

Infection → ↓body stores of Glycogen → catabolism of protein (muscle) and →extreme wasting and rapid weight loss of severely infected patients
• Infection → ↓Body heat production → exhaustion and death

Central nervous system

Hepatic Encephalopathy may occur due to inflammation, Oxidative stress and Intestinal ammonia production on crossing the blood-brain barrieraltered mentation.

Hematological

SepsisDIC
 



Diagramatic representation of pathological bacterial translocation and the associated host response



[17] Contrary to earlier theories, transmucosal migration of bacteria from the gut to the ascitic fluid is no longer considered to play a major role in the etiology of SBP.[16][3]

With respect to compromised host defenses, patients with severe acute or chronic liver disease are often deficient in complement and may also have malfunctioning of the neutrophilic and reticuloendothelial systems.[18]

As for the significance of ascitic fluid proteins, it was demonstrated that cirrhotic patients with ascitic protein concentrations below 1 g/dL were 10 times more likely to develop SBP than individuals with higher concentrations.[19] It is thought that the antibacterial, or opsonic, activity of ascitic fluid is closely correlated with the protein concentration.[1] Additional studies have confirmed the validity of the ascitic fluid protein concentration as the best predictor of the first episode of SBP.[18]

References

  1. 1.0 1.1 1.2 1.3 Runyon BA, Morrissey RL, Hoefs JC, Wyle FA (1985). "Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis". Hepatology. 5 (4): 634–7. PMID 4018735.
  2. 2.0 2.1 2.2 Runyon BA (2004). "Early events in spontaneous bacterial peritonitis". Gut. 53 (6): 782–4. PMC 1774068. PMID 15138202.
  3. 3.0 3.1 Sheer TA, Runyon BA (2005). "Spontaneous bacterial peritonitis". Dig Dis. 23 (1): 39–46. doi:10.1159/000084724. PMID 15920324.
  4. Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A; et al. (1992). "Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration". Hepatology. 16 (3): 724–7. PMID 1505916.
  5. 5.0 5.1 Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P; et al. (2001). "Bacterial translocation of enteric organisms in patients with cirrhosis". J Hepatol. 34 (1): 32–7. PMID 11211904.
  6. 6.0 6.1 Chang CS, Chen GH, Lien HC, Yeh HZ (1998). "Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis". Hepatology. 28 (5): 1187–90. doi:10.1002/hep.510280504. PMID 9794900.
  7. {{cite journal| author=Bauer TM, Steinbrückner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ et al.| title=Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. | journal=Am J Gastroenterol | year= 2001 | volume= 96 | issue= 10 | pages= 2962-7 | pmid=11693333 | doi=10.1111/j.1572-0241.2001.04668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11693333
  8. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J (1984). "Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis". Hepatology. 4 (1): 53–8. PMID 6693068.
  9. Wiest R, Garcia-Tsao G (2005). "Bacterial translocation (BT) in cirrhosis". Hepatology. 41 (3): 422–33. doi:10.1002/hep.20632. PMID 15723320.
  10. Runyon BA, Squier S, Borzio M (1994). "Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis". J Hepatol. 21 (5): 792–6. PMID 7890896.
  11. 11.0 11.1 Ho H, Zuckerman MJ, Ho TK, Guerra LG, Verghese A, Casner PR (1996). "Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis". Am J Gastroenterol. 91 (4): 735–42. PMID 8677940.
  12. 12.0 12.1 12.2 Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J; et al. (2001). "Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection". Dig Dis Sci. 46 (11): 2360–6. PMID 11713936.
  13. 13.0 13.1 Dunn DL, Barke RA, Knight NB, Humphrey EW, Simmons RL (1985). "Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity". Infect Immun. 49 (2): 257–64. PMC 262007. PMID 3894229.
  14. Navasa, Miguel; Follo, Antonio; Filella, Xavier; Jiménez, Wladimiro; Francitorra, Anna; Planas, Ramón; Rimola, Antoni; Arroyo, Vicente; Rodés, Joan (1998). "Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality". Hepatology. 27 (5): 1227–1232. doi:10.1002/hep.510270507. ISSN 0270-9139.
  15. Titó L, Rimola A, Ginès P, Llach J, Arroyo V, Rodés J (1988). "Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors". Hepatology. 8 (1): 27–31. PMID 3257456.
  16. 16.0 16.1 Runyon BA (1988). "Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis". Hepatology. 8 (3): 632–5. PMID 3371881.
  17. 17.0 17.1 Runyon BA, Hoefs JC (1984). "Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis". Hepatology. 4 (6): 1209–11. doi:10.1002/hep.1840040619. PMID 6500513.
  18. 18.0 18.1 Alaniz C, Regal RE (2009) Spontaneous bacterial peritonitis: a review of treatment options. P T 34 (4):204-10. PMID: 19561863
  19. Runyon BA (1986) Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 91 (6):1343-6. PMID: 3770358

Template:WH Template:WS